Literature DB >> 7720757

Drug prescription attitudes and behaviour of general practitioners. Effects of a problem-oriented educational programme.

A Ekedahl1, S I Andersson, B Hovelius, S Mölstad, H Liedholm, A Melander.   

Abstract

A producer-independent, problem-oriented, group-education programme with 2-day meetings on drug treatment in primary health care (PHC) was developed and evaluated. Initially, it was tested on a selected group of general practitioners (district physicians), using a non-exposed group as control. A comprehensive questionnaire was used to test changes in attitudes. There was a significant change in attitudes concerning both general opinions on drugs and drug use, on information about drug treatment, and on use of drugs in selected therapeutic areas. Also, the district physicians became more critical towards information from pharmaceutical companies. Prescribing patterns tended to change in accordance with the attitude changes. Subsequently, the programme was offered to all district physicians (about 550) in the southern Swedish health care region for a 10-year period, with 20-25 district physicians per 2-day meeting. The impact of the programme on the prescribing of a selected group of drugs (antibiotics) was assessed by voluntary registration of prescription by the participants, by regional prescription analyses and by analyses of drug sales data. There were significant, consistent, and sustained changes in the prescribing of antibiotics. The study supports the view that, if drug prescribing in general practice is to be improved, producer-independent, problem-oriented, face-to-face, small-group education on drug treatment is worthwhile.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7720757     DOI: 10.1007/bf00196849

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  The influence of an academic representative on prescribing by general practitioners.

Authors:  F A Newton-Syms; P H Dawson; J Cooke; M Feely; T G Booth; D Jerwood; R T Calvert
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

2.  Impact of education by clinical pharmacists on physician ambulatory care prescribing of generic versus brand-name drugs.

Authors:  J Erramouspe
Journal:  DICP       Date:  1989-10

3.  Clinical pharmacology and primary health care in Europe--a gap to bridge. The WHO Working Group on Clinical Pharmacology in Europe.

Authors:  G Dukes; P K Lunde; A Melander; M Orme; F Sjöqvist; G Tognoni; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Introduction and audit of a general practice antibiotic formulary.

Authors:  A Needham; M Brown; S Freeborn
Journal:  J R Coll Gen Pract       Date:  1988-04

5.  Persistence of improvement in antibiotic prescribing in office practice.

Authors:  W A Ray; W Schaffner; C F Federspiel
Journal:  JAMA       Date:  1985 Mar 22-29       Impact factor: 56.272

6.  Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing".

Authors:  J Avorn; S B Soumerai
Journal:  N Engl J Med       Date:  1983-06-16       Impact factor: 91.245

7.  Improving antibiotic prescribing in office practice. A controlled trial of three educational methods.

Authors:  W Schaffner; W A Ray; C F Federspiel; W O Miller
Journal:  JAMA       Date:  1983-10-07       Impact factor: 56.272

8.  A critical appraisal of the efficacy of continuing medical education.

Authors:  R B Haynes; D A Davis; A McKibbon; P Tugwell
Journal:  JAMA       Date:  1984-01-06       Impact factor: 56.272

9.  Impact of a drug bulletin on the knowledge, perception of drug utility, and prescribing behavior of physicians.

Authors:  P Denig; F M Haaijer-Ruskamp; D H Zijsling
Journal:  DICP       Date:  1990-01

10.  Educational antibiotic advertising.

Authors:  K J Harvey; R Stewart; M Hemming; N Naismith; R F Moulds
Journal:  Med J Aust       Date:  1986-07-07       Impact factor: 7.738

  10 in total
  8 in total

1.  National Prescribing Service: creating an implementation arm for national medicines policy.

Authors:  L M Weekes; J M Mackson; M Fitzgerald; S R Phillips
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

Review 2.  Strategies for promoting judicious use of antibiotics by doctors and patients.

Authors:  E A Belongia; B Schwartz
Journal:  BMJ       Date:  1998-09-05

Review 3.  Prescribing of psychotropics in the elderly: why is it so often inappropriate?

Authors:  Jane R Mort; Rajender R Aparasu
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing.

Authors:  M E van Eijk; J Avorn; A J Porsius; A de Boer
Journal:  BMJ       Date:  2001-03-17

Review 5.  Interventions to improve antibiotic prescribing practices in ambulatory care.

Authors:  S R Arnold; S E Straus
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

6.  Teaching and counselling behaviour: an applied study with community pharmacists.

Authors:  L Leemans; G Laekman
Journal:  Pharm World Sci       Date:  1998-12

7.  A multifaceted approach to decrease inappropriate antibiotic use in a pediatric outpatient clinic.

Authors:  Jaffar A Al-Tawfiq; Amel H Alawami
Journal:  Ann Thorac Med       Date:  2017 Jan-Mar       Impact factor: 2.219

8.  Irrational prescribing of over-the-counter (OTC) medicines in general practice: testing the feasibility of an educational intervention among physicians in five European countries.

Authors:  Christos Lionis; Elena Petelos; Sue Shea; Georgia Bagiartaki; Ioanna G Tsiligianni; Apostolos Kamekis; Vasiliki Tsiantou; Maria Papadakaki; Athina Tatsioni; Joanna Moschandreas; Aristoula Saridaki; Antonios Bertsias; Tomas Faresjö; Ashild Faresjö; Luc Martinez; Dominic Agius; Yesim Uncu; George Samoutis; Jiri Vlcek; Abobakr Abasaeed; Bodossakis Merkouris
Journal:  BMC Fam Pract       Date:  2014-02-17       Impact factor: 2.497

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.